October Pharma S.A.E (OCPH.CA)

Also known as:  OP, October Pharma
Data delayed by 15 minutes
73.00 EGP 0.000.00%
As of 04 DEC 2019 - GMT|Egypt SE

OP Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
1.233%
P/E (Last 12 Month)
21.147
Upside
-
Target Price (Mean)
-
52Wk
63.5 08 JAN
80.19 21 JAN

Open
Data not available
Previous Close
73.00 EGP
Turnover
Data not available
EPS
3.452 EGP
Volume
0
Transactions
0
Market Cap
438.00M EGP
IPO Date
11-Jul-2002
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About October Pharma S.A.ELast updated on: 22 February 2018

Business Summary
Production of branded drugs and multi-vitamins.
Country of Incorporation
Ownership Type
Established In
1987
Primary Sector
Number of Employees
800
Stock Listing
IDStock TypeCurrencyExchangeSymbol
OCPH.CASEOrdinaryEGPEgypt SEOCPH

Contact details

Primary address
October Pharma S.A.E. Building
Street 25
First Industrial Zone, Plot 190
38
Egypt
6th of October City
12566
CONTACT
  • Tel: +20 2-3833-0329
  • Tel: +20 2-3833-0652
  • Tel: +20 2-3833-1832
  • Fax: +20 2-3833-0653
  • Email: www.octoberpharma.com
Region
Giza
All Related News

Saudi Arabia is magnet for foreign investors

A recent World Bank report highlighted the Kingdom’s continued efforts to improve the business climate for domestic and medium-sized businesses

Arab News - Sunday 8 December 2019
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Ahmad Zaghloul Ahmad Mustafa
Managing Director
Dr Wafaa Raafat Gafar
General Manager, Factory
Mr Mohammed Nasib Abdullah Farid
Engineering Director

Board Members

Dr Fouad Mohammed Mohammed El Lafy
Chairman
Dr Ahmad Zaghloul Ahmad Mustafa
Director representing Arab Company for Drug Industries & Medical Appliances
Mr Shaaban Mohammed Mohammed
Director representing Joint Arab Investment Corporation
All People

Company information provided by © 2019 Thomson Reuters

Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
CAIRO PHARMAC.39.470 EGP0.00
EGYPT INTL PHRM69.000 EGP0.00
ALX. PHARMACEUT.100.000 EGP0.00
MINAPHARM PHARMA84.950 EGP0.00
ARAB PHARM40.940 EGP0.00
GLAXO EGYPT19.760 EGP0.00
All Peers

Most Viewed Stocks

Stock Market Data

Powered By Knowledge Direct

Stock Screener

All Stocks